|Articles|June 9, 2004
FDA approves ISTA product, asked to evaluate another
On May 6 the FDA approved ISTA Pharmaceutical's new drug application (NDA) for lyophilized, ovine hyaluronidase for injection (Vitrase) for use as a spreading agent to facilitate the dispersion and absorption of other drugs.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Everest Medicines acquires Greater China rights to Aceclidine Presbyopia Eye Drop (VIZZ)
2
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
3
Self-Screening for Ocular Surface Malignancies Using a Smartphone
4
Durability and Unmet Needs in Retinal Vascular Diseases
5

















